|
|
Vaccine Detail
|
KLH-pulsed autologous dendritic cell vaccine |
| Vaccine Information |
- Vaccine Name: KLH-pulsed autologous dendritic cell vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: whole cell cancer vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Antigen: KLH (NCT00868114)
- Immunization Route: intratumoral
- Description: Autologous dendritic cells are pulsed with KLH for this vaccination, combined with radiation or a gene therapy agent, TNFerade. TNFerade or radiation serves to generate cell death stimulating the immune response. The dendritic cell vaccine may direct a distant and lasting effective anti-tumor immune response to achieve a local and systemic clinical benefit. (NCT00868114)
|
| Host Response |
|
|
| References |
NCT00868114: Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer [https://clinicaltrials.gov/study/NCT00868114]
|
|
